(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

OAKJF

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

OAKJF

ST13

US500000079333714

Classe

9, 42

Pedido

79333714

Registro

6886715

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

28

Atualização mais recente

21/03/2023

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

9, 42

Data de depósito

26/11/2021

Data de registro

01/11/2022

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

01/11/2022

Última transação

01/11/2022

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

25

Localização do titular

CH

Examinador

RADEMACHER, APRIL

Unidade examinadora

L80

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

NOVARTIS AG

Representantes

Maury M. Tepper, III Tepper & Eyster, PLLC

Classificação técnica

Classes Nice

Classe 9Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 9

Downloadable computer software and computer hardware for evaluationverification and administration of medical data for medical and diagnostic purposes in the field of osteoarthritis; downloadable computer software for recordinganalyzingreporting and managing patient medical information in the field of osteoarthritis; downloadable mobile application for use in the electronic transmission of patient medical information in the field of osteoarthritis; downloadable computer software for use in the electronic transmission of patient data; downloadable computer software having a processing algorithm used to identifyfilteranalyzevisualize and manage data from biological information in the field of osteoarthritis; downloadable computer software for use in operating medical decision support systems; downloadable computer software for the medical field for diagnostic testing and analysis of human data and patient medical information in the field of osteoarthritis; downloadable artificial intelligence software for healthcare for diagnostic testing and analysis of human data and patient medical information in the field of osteoarthritis; downloadable software using algorithms for the diagnostic testing and analysis of human data in the field of osteoarthritis; downloadable software applications for medical and/or surgical applications for diagnostic testing and analysis of human data and patient medical information in the field of osteoarthritis; downloadable computer software for evaluationverification and administration of medical data in the field of osteoarthritis; data acquisition devicesdownloadable computer software and computer hardware for recordinganalyzingreporting and managing patient medical information in the field of osteoarthritis

Classe 42

Providing medical and scientific research information in the field of pharmaceutical and clinical trials and studies; Providing scientific information in the field of pharmaceutical and clinical trials via the Internetelectronic media and data banks; providing information concerning clinical study results and clinical study data by means of interactive web sites; providing scientific information in the field of pharmaceutical and clinical trials via Internet pageselectronic tools and data banks; providing information concerning clinical studies and results thereof from a data bank which can be consulted online

Publicações

Histórico de despachos e eventos da marca no USPTO.

28 publicações encontradas

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

21/03/2023

FICS

FINAL DISPOSITION NOTICE SENT TO IB

28/02/2023

FIMP

FINAL DISPOSITION PROCESSED

28/02/2023

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

01/02/2023

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

01/11/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

01/11/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

16/08/2022

PUBO

PUBLISHED FOR OPPOSITION

16/08/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

27/07/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

13/07/2022

RFNT

REFUSAL PROCESSED BY IB

07/06/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

20/05/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

20/05/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

20/05/2022

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

14/05/2022

RFRR

REFUSAL PROCESSED BY MPU

13/05/2022

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

31/03/2022

CNRT

NON-FINAL ACTION WRITTEN

30/03/2022

DOCK

ASSIGNED TO EXAMINER

17/03/2022

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

07/03/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/03/2022

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

07/03/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/03/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/03/2022

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

07/03/2022

MAFR

APPLICATION FILING RECEIPT MAILED

26/02/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

22/02/2022

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

17/02/2022

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace OAKJF ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.